Rigel Pharmaceuticals
(NASDAQ) RIGL
Rigel Pharmaceuticals Financials at a Glance
Market Cap
$475.13M
Revenue (TTM)
$294.28M
Net Income (TTM)
$367.02M
EPS (TTM)
$18.91
P/E Ratio
1.36
Dividend
$0.00
Beta (Volatility)
1.35 (Average)
Dividend
$0.00
Beta (Volatility)
1.35 (Average)
Price
$25.80
Volume
5,522
Open
$25.96
Price
$25.80
Volume
5,522
Open
$25.96
Previous Close
$25.80
Daily Range
$25.72 - $26.29
52-Week Range
$15.50 - $52.24
Dividend
$0.00
Beta (Volatility)
1.35 (Average)
Price
$25.80
Volume
5,522
Open
$25.96
Previous Close
$25.80
Daily Range
$25.72 - $26.29
52-Week Range
$15.50 - $52.24
RIGL News
RIGL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rigel Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
174
CEO
Raul R. Rodriguez, MBA
Website
www.rigel.comHeadquarters
South San Francisco, CA 94080, US
RIGL Financials
Key Financial Metrics (TTM)
Gross Margin
93%
Operating Margin
43%
Net Income Margin
1%
Return on Equity
186%
Return on Capital
30%
Return on Assets
71%
Earnings Yield
73.53%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$475.13M
Shares Outstanding
18.47M
Volume
5.52K
Short Interest
0.00%
Avg. Volume
388.46K
Financials (TTM)
Gross Profit
$274.66M
Operating Income
$125.47M
EBITDA
$127.88M
Operating Cash Flow
$75.66M
Capital Expenditure
$0.00
Free Cash Flow
$75.66M
Cash & ST Invst.
$154.96M
Total Debt
$53.30M
Rigel Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$69.80M
+21.2%
Gross Profit
$63.85M
+23.2%
Gross Margin
91.47%
N/A
Market Cap
$475.13M
N/A
Market Cap/Employee
$2.93M
N/A
Employees
162
N/A
Net Income
$268.06M
+1769.2%
EBITDA
$21.33M
+20.0%
Quarterly Fundamentals
Net Cash
$101.65M
+485.7%
Accounts Receivable
$51.76M
+24.4%
Inventory
$11.51M
+91.7%
Long Term Debt
$22.88M
-56.3%
Short Term Debt
$30.43M
+302.6%
Return on Assets
71.46%
N/A
Return on Invested Capital
30.28%
N/A
Free Cash Flow
$21.99M
+51.9%
Operating Cash Flow
$21.98M
+51.6%